Shelter Pharma Reports Zero Deviation in Preferential Issue Fund Utilization
Shelter Pharma Ltd 路 Others (Uncategorized) 路 07 Nov 2026, 11:23 pm
Shelter Pharma Reports Zero Deviation in Preferential Issue Fund Utilization Shelter Pharma confirmed nil deviation or variation in utilizing proceeds from its convertible warrant preferential issue for the half-year ended 30th Sep'26. Total funds raised amounted to Rs. 2,602.50 lakh, comprising Rs. 930.35 lakh from 25% warrant subscription (88.08 lakh warrants at Rs. 42.25/share) and Rs. 1,672.15 lakh from converting 52.77 lakh warrants. The company fully deployed Rs. 2,531.20 lakh toward working capital requirements and Rs. 71.30 lakh for general corporate purposes, strictly adhering to objects approved in its 23rd Jul'25 EGM.
Original exchange filing (PDF)
More announcements from Shelter Pharma Ltd
- Attached herewith Financial Results for Half year ended 30th September, 2026 路 07 Nov 2026
- With reference to the subject matter and pursuant to the Regulation 30, 32 & 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 .... 路 07 Nov 2026
- Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) .... 路 07 Nov 2026
- Attached here with order updates recieved on 28.10.2026 路 30 Oct 2026
- Conversion of Warrants into Equity Shares 路 16 Oct 2026
- Outcome of the Board Meeting held on Friday, October 16, 2026 for conversion of warrants into Equity Shares 路 16 Oct 2026
- Attached herewith Intimation for Regularization of Ms. Vinita Gadhavi as Non Executive Independent Director of the Company. 路 30 Sept 2026
- Attached herewith Voting Results along with Scrutinizer Report of Shelter Pharma Limited 路 30 Sept 2026
